Dianthus Therapeutics Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, Dianthus Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $139.06. The average 1-year stock price forecast is 69.07% higher than the current stock price, while the lowest is $113 (+37.39%) and the highest is $200 (+143.16%).

Price Target: $139.06 (+69.07%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$113	$139.06	$133.5	$200
Change	+37.39%	+69.07%	+62.31%	+143.16%

Analyst Ratings

The average analyst rating for Dianthus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	15	15	15	15	16	17
Buy	0	0	0	0	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	15	15	15	17	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Adam Walsh Roth MKM	Roth MKM	Buy Initiates $113	Buy	Initiates	$113	+37.39%	Oct 26, 2026
Sadia Rahman Wells Fargo	Wells Fargo	Buy Maintains $135	Buy	Maintains	$135	+64.13%	Oct 16, 2026
Swayampakula Ramakanth H.C. Wainwright	H.C. Wainwright	Buy Reiterates $158	Buy	Reiterates	$158	+92.10%	Oct 15, 2026
Rami Katkhuda LifeSci Capital	LifeSci Capital	Buy Maintains $125	Buy	Maintains	$125	+51.98%	Sep 29, 2026
Brian Cheng J.P. Morgan	J.P. Morgan	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Sep 24, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.92M

from 2.04M

-5.77%

from 2.04M

Revenue Next Year

1.82M

from 1.92M

-4.97%

from 1.92M

EPS This Year

-3.81

from -4.20

EPS Next Year

-4.61

from -3.81

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.48M	6.42M	2.83M	6.24M	2.04M	1.92M
Revenue Growth	-	334.76%	-55.96%	120.63%	-67.35%	-5.77%
Gross Profit	1.48M	6.42M	2.83M	6.24M	2.04M	1.92M
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Income	-13.09M	-29.71M	-48.17M	-101.86M	-177.93M	-241.83M
Net Income	-13.11M	-28.48M	-43.56M	-84.97M	-162.34M	-205.99M
EPS	-	-	-	-	-4.20	-3.81
Free Cash Flow	-	-	-	-	-129.27M	-144.02M
No. Analysts	-	-	-	-	-	15

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	3.2M
Avg	1.9M
Low	900,000

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	58.3%
Avg	-5.8%
Low	-55.8%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-3.43
Avg	-3.81
Low	-4.10

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-